Literature DB >> 15784553

Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.

Sheetij Dutta1, J David Haynes, Arnoldo Barbosa, Lisa A Ware, Jeffrey D Snavely, J Kathleen Moch, Alan W Thomas, David E Lanar.   

Abstract

Antibodies against apical membrane antigen 1 (AMA-1) of Plasmodium falciparum inhibit merozoite invasion into erythrocytes. Invasion-inhibitory polyclonal AMA-1 antibodies inhibit secondary proteolytic processing and surface redistribution of AMA-1 on merozoites. We present evidence supporting inhibition of processing and redistribution as probable causes of inhibition of invasion by polyclonal antibodies. Polyclonal anti-AMA-1 was much more inhibitory than monoclonal antibody (MAb) 4G2dc1 in an invasion assay. Although both polyclonal and monoclonal immunoglobulin G (IgG) inhibited secondary processing of the 66-kDa form of AMA-1, only polyclonal IgG caused its anomalous processing, inhibited its redistribution, and cross-linked soluble forms of AMA-1 on merozoites. Moreover, Fab fragments of polyclonal IgG that fail to cross-link did not show the enhancement of inhibitory effect over intact IgG, as observed in the case of Fab fragments of MAb 4G2dc1. We propose that although blocking of biologically important sites is a common direct mode of action of anti-AMA-1 antibodies, blocking of AMA-1 secondary processing and redistribution are additional indirect inhibitory mechanisms by which polyclonal IgG inhibits invasion. We also report a processing inhibition assay that uses a C-terminal AMA-1-specific MAb, 28G2dc1, to detect merozoite-bound remnants of processing (approximately 20 kDa from normal processing to 48 and 44 kDa and approximately 10 kDa from anomalous processing to a 52-kDa soluble form of AMA-1). The ratio of intensity of 10-kDa bands to the sum of 10- and 20-kDa bands was positively correlated with inhibition of invasion by polyclonal antibodies. This assay may serve as an important immunochemical correlate for inhibition of invasion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784553      PMCID: PMC1087451          DOI: 10.1128/IAI.73.4.2116-2122.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites.

Authors:  Julie Healer; Simon Crawford; Stuart Ralph; Geoff McFadden; Alan F Cowman
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

2.  Automated synchronization of Plasmodium falciparum parasites by culture in a temperature-cycling incubator.

Authors:  J David Haynes; J Kathleen Moch
Journal:  Methods Mol Med       Date:  2002

3.  Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.

Authors:  P V Lalitha; Lisa A Ware; Arnoldo Barbosa; Sheetij Dutta; J Kathleen Moch; J David Haynes; Bader B Fileta; Charles E White; David E Lanar
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage.

Authors:  Steven A Howell; Isabelle Well; Suzanne L Fleck; Catherine Kettleborough; Christine R Collins; Michael J Blackman
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

5.  In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.

Authors:  Michael C Kennedy; Jin Wang; Yanling Zhang; Aaron P Miles; Farideh Chitsaz; Allan Saul; Carole A Long; Louis H Miller; Anthony W Stowers
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.

Authors:  Anthony W Stowers; Michael C Kennedy; Brian P Keegan; Allan Saul; Carole A Long; Louis H Miller
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.

Authors:  G H Mitchell; A W Thomas; G Margos; A R Dluzewski; L H Bannister
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites.

Authors:  Olivier Silvie; Jean-François Franetich; Stéphanie Charrin; Markus S Mueller; Anthony Siau; Myriam Bodescot; Eric Rubinstein; Laurent Hannoun; Yupin Charoenvit; Clemens H Kocken; Alan W Thomas; Geert-Jan Van Gemert; Robert W Sauerwein; Michael J Blackman; Robin F Anders; Gerd Pluschke; Dominique Mazier
Journal:  J Biol Chem       Date:  2003-12-15       Impact factor: 5.157

9.  High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.

Authors:  Clemens H M Kocken; Chrislaine Withers-Martinez; Martin A Dubbeld; Annemarie van der Wel; Fiona Hackett; Augusto Valderrama; Michael J Blackman; Alan W Thomas
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites.

Authors:  Sheetij Dutta; J David Haynes; J Kathleen Moch; Arnoldo Barbosa; David E Lanar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-02       Impact factor: 11.205

View more
  31 in total

1.  Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.

Authors:  David K Moss; Edmond J Remarque; Bart W Faber; David R Cavanagh; David E Arnot; Alan W Thomas; Anthony A Holder
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

2.  The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody.

Authors:  A M Coley; K Parisi; R Masciantonio; J Hoeck; J L Casey; V J Murphy; K S Harris; A H Batchelor; R F Anders; M Foley
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Structural basis of antigenic escape of a malaria vaccine candidate.

Authors:  Sheetij Dutta; Seung Yeon Lee; Adrian H Batchelor; David E Lanar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-16       Impact factor: 11.205

4.  Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.

Authors:  Karen S Harris; Joanne L Casey; Andrew M Coley; John A Karas; Jennifer K Sabo; Yen Yee Tan; Olan Dolezal; Raymond S Norton; Andrew B Hughes; Denis Scanlon; Michael Foley
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

5.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

6.  Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.

Authors:  Changling Li; Rui Wang; Yuan Wu; Dongmei Zhang; Zhicheng He; Weiqing Pan
Journal:  Malar J       Date:  2010-04-12       Impact factor: 2.979

7.  Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.

Authors:  Ute Woehlbier; Christian Epp; Fiona Hackett; Michael J Blackman; Hermann Bujard
Journal:  Malar J       Date:  2010-03-18       Impact factor: 2.979

8.  Alanine mutagenesis of the primary antigenic escape residue cluster, c1, of apical membrane antigen 1.

Authors:  Sheetij Dutta; Lisa S Dlugosz; Joshua W Clayton; Christopher D Pool; J David Haynes; Robert A Gasser; Adrian H Batchelor
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

9.  Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.

Authors:  Kwadwo A Kusi; Bart W Faber; Alan W Thomas; Edmond J Remarque
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

10.  An inhibitory antibody blocks interactions between components of the malarial invasion machinery.

Authors:  Christine R Collins; Chrislaine Withers-Martinez; Fiona Hackett; Michael J Blackman
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.